Impact of Chemotherapy Based Induction Using Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Versus Novel Agent Induction in Patients Undergoing Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)

Authors :: Lindsay Dozeman
Christopher Strouse
Margarida Silverman
Jillna Claus
Yogesh Jethava
Sarah L. Mott
Allyson Schultz
Praveen Vikas
Umar Farooq
Michael H. Tomasson
M. Hasib Sidiqi
Kalyan Nadiminti
Source :: Biology of Blood and Marrow Transplantation. 25:S399-S400
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Transplantation
Chemotherapy
Cyclophosphamide
business.industry
medicine.medical_treatment
Hematology
Cisplatin/doxorubicin
medicine.disease
Autologous stem-cell transplantation
medicine
Cancer research
In patient
business
Dexamethasone
Etoposide
Multiple myeloma
medicine.drug

Full Text Access

Tools